Ballroom AB

Plenary Session III - Acta Biomaterialia Gold Medal

Medical and Dental treatments including surgical implant devices constituted and fabricated from Biomaterials account for about 14 million clinical applications per year in the USA. As we transition from the Biotolerant and Surface Bioactive to Biodegradable (Tissue Engineered Medical Products-TEMPS and Regenerative Medicine) types of Biomaterials, it seems appropriate that we consider what lessons may be transferred from prior experience(s) gained by participation in the discipline and SFB.